|
Quotes & Info
|
| AVXL.OB > SEC Filings for AVXL.OB > Form 8-K on 21-Dec-2007 | All Recent SEC Filings |
21-Dec-2007
Change in Directors or Principal Officers
Effective December 17, 2007, Dr. Cameron Durrant was appointed to the board of directors of our company.
Dr. Cameron Durrant:
Before joining Johnson & Johnson, Dr. Durrant was president and CEO of Pediamed Pharmaceuticals. Dr. Durrant's background also includes executive-level positions with Merck & Co., GlaxoSmithKline and Pharmacia (now Pfizer). Dr. Durrant was a regional winner and national finalist for Ernst & Young's Entrepreneur of the Year award in 2005. Dr. Durrant holds a MBA from Henley Management College at Oxford and a MB and BCh (equivalent to American MD degree) from the Welsh National School of Medicine in Cardiff, U.K.
There are no family relationships between any of our directors or executive officers.
|
|